October 12th, 2015 partners from Aristotle University of Thessaloniki, Wageningen University, Karolinska Institutet and AB Mando met in Stockholm to discuss the following 1) what SPLENDID may offer on risk assessment for eating disorder and obesity, 2) set goals for the analysis of the collected data and 3) define the protocols for the second pilot. A primary screening pilot is planned in December 2015 with 150-170 students. A second round with fewer students (~50) is planned in January 2016. A fruitful meeting was also held with the teachers at the International English School in Stockholm to plan the upcoming experiments.